Journal of Taibah University Medical Sciences

作者在投稿时必须声明在稿件准备过程中使用了生成式人工智能工具。 模型中文摘要

Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…

所有作者均须在研究设计或数据获取或分析、论文撰写或修改、以及最终定稿批准方面做出实质性贡献，且只有注册于Editorial Manager的作者才会被考虑。 模型中文摘要

All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted. Only those authors and co authors who are registered in Editorial Manager …

所有作者必须披露可能不当影响其工作的财务和个人关系，并随稿件一并上传利益冲突与作者声明表，该表为强制要求。 模型中文摘要

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. See also https://www.elsevier.com/conflictsofint…

稿件须声明研究已获相关机构伦理委员会批准（注明委员会名称、批准号和日期）且受试者已知情同意，动物实验须声明其饲养符合机构指南。 模型中文摘要

Include a statement that the work has been approved by the appropriate ethical committees related to the institution(s) in which it was performed (include name of the ethics committee, approval number and date) and that subjects gave informed consent to the work. Studies involving experiments with animals must state that their care was in accordance with institution guidelines.

文章被接受后，作者将被要求签署许可协议，开放获取文章的第三方再使用取决于作者选择的用户许可。 模型中文摘要

Upon acceptance of an article, authors will be asked to complete a 'License Agreement' (see more information on this). Permitted third party reuse of open access articles is determined by the author's choice of user license.Author rightsAs an author you (or your employer or institution) have certain rights to reuse your work. More information.

有关本期刊开放获取出版的更多信息，请访问开放获取页面。 模型中文摘要

Please visit our Open Access page for more information about open access publishing in this journal.

本期刊实行双盲匿名审稿，稿件通常至少送交两名独立专家评审，编辑对接受或拒绝拥有最终决定权。 模型中文摘要

This journal operates a double anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor'…

期刊接受最高20%的相似度指数，达到或超过20%的投稿将被视为抄袭且不予处理。 模型中文摘要

The journal is a member of Committee of Publications Ethics (COPE) and accepts a maximum threshold of 20% similarity index. Any submission with similarity index of 20% or more will be considered as plagiarism and the article will not be processed by the journal.

预印本若已正式发表，应引用正式出版物；尚未正式发表但与工作密切相关的预印本可以引用，但须明确标注并提供预印本DOI。 模型中文摘要

Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If there are preprints that are central to your work or that cover crucial developments in the topic, but are not yet formally published, these may be referenced. Preprints should be clearly marked as such, for example by including the word preprint, or the nam…

作者应按EQUATOR Network的相应指南和清单准备稿件，如观察性研究用STROBE、临床试验用CONSORT、系统综述用PRISMA、诊断准确性研究用STARD，并随投稿附上相应清单。 模型中文摘要

Authors should prepare their manuscripts in accordance with the appropriate guidelines(s) and/or checklist(s) for each type of article, as defined by the EQUATOR Network. Specifically, the following guidelines/checklists should be used: STROBE for Observational Studies; CONSORT for Clinical Trial/Experimental Studies; PRISMA for Systematic Review and Meta-Analysis; and STARD for Diagnostic Accurac…